geoopen

In Vivo efficacy assessment of the CDK4/6 inhibitor palbociclib and the PLK1 inhibitor volasertib in Human Chordoma Xenografts

GEO Series GSE216419. Homo sapiens. 18 samples. Type: Genome variation profiling by high throughput sequencing; Expression profiling by high throughput sequencing.

ShareScore

24/100

Overall dataset sharing score

Score breakdown

These five areas show where the dataset supports — or may limit — practical reuse.

Stewardship: 4
Harmonization: 8
Access: 4
Reuse readiness: 0
Engagement: 8

Topics

Homo sapiens Genome variation profiling by high throughput sequencing; Expression profiling by high throughput sequencing GEO gene expression